Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection

Blood

Volumn 117, Issue 6, 2011, Pages 2033-2043

  Clark, Stephen R ^a   Guy, Christopher J ^a   Scurr, Martin J ^a   Taylor, Philip R ^a   Kift Morgan, Ann P ^a   Hammond, Victoria J ^a   Thomas, Christopher P ^a   Coles, Barbara ^a   Roberts, Gareth W ^a   Eberl, Matthias ^a   Jones, Simon A ^a   Topley, Nicholas ^a   Kotecha, Sailesh ^a   O'Donnell, Valerie B ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALCIUM ION; CYTOCHALASIN D; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICOSANOID; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; SUPEROXIDE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; ENZYME INHIBITION; ESTERIFICATION; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79951507354     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-278887     Document Type: Article

References (39)

1. Werz O, Steinhilber D. Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther. 2006; 112(3):701-718. (Pubitemid 44592614)
2. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: underappreciated mediators of innate immune responses. J Immunol. 2005;174(2):589-594. (Pubitemid 40103563)
3. Benjamim CF, Canetti C, Cunha FQ, Kunkel SL, Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol. 2005;174(3):1616-1620.
4. Poeckel D, Zemski Berry KA, Murphy RC, Funk CD. Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis inApoE knock-out mice. J Biol Chem. 2009;284(31):21077-21089.
5. Guidot DM, Repine MJ, Westcott JY, Repine JE. Intrinsic 5-lipoxygenase activity is required for neutrophil responsivity. Proc Natl Acad Sci U S A. 1994;91(17):8156-8159. (Pubitemid 24253905)
6. Hubbard NE, Erickson KL. Role of 5′-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function. Cell Immunol. 1995;160(1):115-122.
7. Serhan CN, Chiang N, VanDyke TV. Resolving inflammation: dual anti-inflammatory and proresolution lipid mediators Nat Rev Immunol. 2008;8(5):349-361. (Pubitemid 351595216)
8. Morgan AH, Dioszeghy V, Maskrey BH, et al. Phosphatidylethanolamine- esterified eicosanoids in the mouse: tissue localization and inflammation-dependent formation in Th-2 disease. J Biol Chem. 2009;284(32):21185-21191.
9. Thomas CP, Morgan LT, Maskrey BH, et al. Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation. J Biol Chem. 2010;285(10):6891- 6903.
10. Maskrey BH, Bermudez-Fajardo A, Morgan AH, et al. Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase. J Biol Chem. 2007;282:(28)20151-20163. (Pubitemid 47100012)
11. Arai M, Imai H, Metori A, Nakagawa Y. Preferential esterification of endogenously formed 5-hydroxyeicosatetraenoic acid to phospholipids in activated polymorphonuclear leukocytes. Eur J Biochem. 1997;244(2):513-519. (Pubitemid 27110755)
12. Stenson WF, Parker CW. Metabolism of arachidonic acid in ionophore-stimulated neutrophils. Esterification of a hydroxylated metabolite into phospholipids. J Clin Invest. 1979;64(5):1457-1465.
13. Brezinski ME, Serhan CN. Selective incorporation of (15S)- hydroxyeicosatetraenoic acid in phosphatidylinositol of human neutrophils: agonist-induced deacylation and transformation of stored hydroxyeicosanoids. Proc Natl Acad Sci U SA. 1990;87(16):6248-6252.
14. Richards CF, Campbell WB. Incorporation of hydroxyeicosatetraenoic acids into cellular lipids of adrenal glomerulosa cells: inhibition of aldosterone release by 5-HETE. Prostaglandins. 1989; 38(5):565-580. (Pubitemid 20003448)
15. Segal AW, Peters TJ. Analytical subcellular fractionation of human granulocytes with special reference to the localization of enzymes involved in microbicidal mechanisms. Clin Sci Mol Med. 1977;52(4):429-442. (Pubitemid 8074196)
16. Piraino B, Bailie GR, Bernardini J, et al Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107-131.
17. Roberts GW, Baird D, Gallagher K, et al Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysis. J Am Soc Nephrol. 2009;20:1895-1900.
18. Morgan AH, Hammond VJ, Morgan L, et al Quantitative assays for esterified oxylipins generated by immune cells. Nature Protocols. 2010;12: 1919-1931.
19. Brinkmann V, Laube B. Abed U, Goosmann C, Zychlinsky A. Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp. 2010; 24(36):pii, 1724 doi:10.3791/1724.
20. Clark SR, Coffey MJ, Maclean R, et al. Characterization of nitric oxide consumption pathways by normal, chronic granulomatous disease and myeloperoxidase- deficient human neutrophils. J Immunol. 2002;169(10):5889-5896. (Pubitemid 35291694)
21. McLoughlin RM, Witowski J, Robson RL, et al. Interplay between IFN-gamma and IL- 6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest. 2003;112(4): 598-607. (Pubitemid 38056344)
22. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A. 1975;72(3):1059-1062.
23. Selvatici R, Falzarano S, Mollica A, Spisani S. Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol. 2006;534(1-3):1-11. (Pubitemid 43384177)
24. Radmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem Sci. 2007;32(7): 332-341. (Pubitemid 47021417)
25. Boden SE, Bertsche T, Ammon HP, Safayhi H. MEK-1/2 inhibition prevents 5-lipoxygenase translocation in N-formylpeptide-challenged human neutrophils. Int J Biochem Cell Biol. 2000; 32(10):1069-1074.
26. Abramovitz M, Wong E, Cox ME, Richardson CD, Li C, Vickers PJ. 5-lipoxygenase- activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem. 1993;215(1): 105-111. (Pubitemid 23211131)
27. Pouliot M, McDonald PP, Krump E, et al. Colocalization of cytosolic phospholipase A2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem. 1996;238(1): 250-258. (Pubitemid 26164775)
28. Gijon MA, Riekhof WR, Zarini S, Murphy RC, Voelker DR. Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J Biol Chem. 2008;283(44):30235-30245.
29. Morgan LT, Thomas CP, Kuhn H, O'Donnell VB. Thrombin-activated human platelets acutely generate oxidized docosahexanoic-acid-containing phospholipids via 12-lipoxygenase. Biochem J. 2010;431(1):141-148.
30. Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons Trends Immunol. 2009;30(11):513-521.
31. Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007; 13(4):463-469. (Pubitemid 46559832)
32. Hattar K, Fink L, Fietzner K, et al. Cell density regulates neutrophil IL-8 synthesis: role of IL-1 receptor antagonist and soluble TNF receptors. J Immunol. 2001;166(10):6287-93.
33. Beckman JK, Gay JC, Brash AR, et al. Simulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils. Lipids. 1985;20(5):318-321. (Pubitemid 15086430)
34. Bailie B, Standiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J Immunol. 1996;157(12): 5221-5224. (Pubitemid 126448936)
35. Mancuso P, Lewis C, Serezani CH, Goel D, Peters-Golden M. Intrapulmonary administration of leukotriene B4 enhances pulmonary host defense against pneumococcal pneumonia. Infect Immun. 2010;78(5):2264-2271.
36. Yamada M, Proia AD. 8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea. Cornea. 2000;19(3):S13-S20. (Pubitemid 30327280)
37. Lysz TW, Arora JK, Lin C, Zelenka PS. 12(S)-hydroxyeocisatetraenoic acid regulates DNA synthesis and protooncogene expression induced by epidermal growth factor and insulin in rat lens epithelium. Cell Growth Differ. 1994;5(10):1069-1076. (Pubitemid 24312282)
38. von Schlieffen E, Oskolkova OV, Schabbauer G, et al. Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2009;29(3):356-362.
39. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol. 2003;14(5):421-430. (Pubitemid 37297296)